Clinical Roundup Keytruda + chemo improved PFS as first-line therapy for advanced or recurrent endometrial carcinoma, regardless of MMR status March 31, 2023Vol.49 No.13
Clinical Roundup Phase III RUBY trial demonstrates potential of Jemperli + chemo to redefine treatment of advanced or recurrent endometrial cancer March 31, 2023Vol.49 No.13
Clinical Roundup Sylvester investigators identify potential targets to overcome treatment resistance in TNBC March 31, 2023Vol.49 No.13
Clinical Roundup Kisqali phase III NATALEE trial meets primary endpoint at interim analysis demonstrating clinically meaningful benefit in early breast cancer March 31, 2023Vol.49 No.13
Clinical Roundup Phase II study shows surgery is an effective alternative to chemo and radiation for early metastatic testicular cancer March 31, 2023Vol.49 No.13
Clinical Roundup Study shows that patients receiving CAR T-cell therapy have improved QOL six months post-treatment March 31, 2023Vol.49 No.13
Clinical Roundup MD Anderson study shows microbiome-based biomarkers may be used to predict to CAR T-cell therapy response March 31, 2023Vol.49 No.13
Clinical Roundup Study finds diverse differences in microbes in breast tumors from patients of different races March 31, 2023Vol.49 No.13
Clinical Roundup University of Cincinnati scientists develop radiation therapy delivery approach using engineered bacteria March 31, 2023Vol.49 No.13
Clinical Roundup Combination therapy shows potential as novel treatment for adenoid cystic carcinoma in phase II study March 31, 2023Vol.49 No.13
